In process, Nurses Information and Communication Guidlene on Biosimilars
Two weeks ago the ESNO focus group on Biosimilar had there last meeting and workshop to finalise the last draft, ready to consult all constituancies. It is a collaborative innitiative of a group of ESNO members with support of Medicine for Europe, EFPIA and Europa-Bio.
This information and communication guide for nurses is designed to provide support and information for nurses working with patients who are switching between similar biological medicines – this could be a switch between the original biologic medicine (known as the reference product or the originator product) and a biosimilar medicine (or vice versa), or between biosimilars.
This information and communication guide for nurses is designed to provide support and information for nurses working with patients who are switching between similar biological medicines – this could be a switch between the original biologic medicine (known as the reference product or the originator product) and a biosimilar medicine (or vice versa), or between biosimilars.
The final publication and release is expected in June 2018. The follow-up will be in an online version and available in 23 European languages,